Evonik Industries has acquired SurModics Pharmaceuticals Inc., a subsidiary of SurModics Inc., by and through its U.S. affiliate, Evonik Degussa Corporation.
The acquisition gives Evonik ownership of SurModics’ parenteral dosage forms services and bioresorbable polymers business.
The new Evonik site will be named Birmingham Laboratories and all employees of SurModics Pharmaceuticals Inc. will transfer to Evonik.
The Birmingham, Alabama-based business will be integrated in Evonik Degussa Corporation, headquartered in Parsippany, N.J.
Release Date: Nov. 18, 2011
Source: Evonik Industries